US Physical Therapy (USPH) Tops Q4 EPS by 25c, Revenues Beat
Tweet
Share
E-mailGet Alerts USPH Hot Sheet
Price: $79.35 +0.90%
Revenue Growth %: +8.5%
Financial Fact:
Net patient revenues: 86.41M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +8.5%
Financial Fact:
Net patient revenues: 86.41M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
US Physical Therapy (NYSE: USPH) reported Q4 EPS of $1.08, $0.25 better than the analyst estimate of $0.83. Revenue for the quarter came in at $117.47 million versus the consensus estimate of $116.36 million.
For earnings history and earnings-related data on US Physical Therapy (USPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Dell’s earning report was bullish for Intel CPU demand, analyst says
- Goldman Sachs Downgrades Shurgard Self Storage SA (SHUR:BB) to Neutral
Create E-mail Alert Related Categories
Corporate News, EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
